Manager TitleAgeSince
Chief Executive Officer 59 16/09/2024
Director of Finance/CFO 58 25/09/2023
Chief Tech/Sci/R&D Officer 56 -
Director TitleAgeSince
Chairman 74 06/11/2019
Director/Board Member 64 01/11/2019
Chairman 63 04/01/2024
Date Insider Type Main position Quantity % Market Cap.
22/07/25Buy

Director

657,822 0.8218%
04/07/25
Kohlberg Kravis Roberts & Co. LP
BuyCompany 3,763,797 4.7019%
30/06/25
Kohlberg Kravis Roberts & Co. LP
BuyCompany 20 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%+0.14% - - 1.22B
-2.69%+5.16%+2.71%-27.20% 16.5B
-5.09%-7.73%+19.73%+39.52% 1.52B
-0.65%-1.61%-30.93%+26.25% 1.1B
+2.00%+0.88%-51.95%-83.55% 922M
-4.81%-9.65%-26.11%-54.16% 640M
-4.26%+1.87%-38.83%-56.04% 587M
0.00%-2.28%+20.49%-54.56% 434M
-1.57%0.00%-54.56%-60.75% 385M
-2.02%-0.58%-24.11%-23.94% 341M
Average -1.89%-1.80%-20.40%-32.71% 2.49B
Weighted average by Cap. -2.44%+2.86%-2.99%-24.96%
Logo Biotage AB
Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage’s offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Company’s offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.
Employees
622
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
  1. Stock Market
  2. Stocks
  3. BIOT Stock